{"id":"W4387424812","doi":"10.1007/s00277-023-05483-0","title":"Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria","year":2023,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Alexion Pharmaceuticals; Universität Ulm; AstraZeneca","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Eculizumab; Internal medicine; Post-hoc analysis; Hematology; Hemoglobinuria; Quality of life (healthcare); Randomized controlled trial; Anemia; Physical therapy; Immunology; Complement system; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007242231,0.0003156883,0.002626372,0.001141359,0.00005498074,0.000007931304,0.0003380089,0.0001150139,0.00007243402],"category_scores_gemma":[0.000319043,0.0002436345,0.0001664584,0.0008239088,0.0002762494,0.0001004288,0.0003837297,0.0001057753,8.111417e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002704155,"about_ca_system_score_gemma":0.0001138187,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001269447,"about_ca_topic_score_gemma":0.001566071,"domain_scores_codex":[0.9959133,0.0005631146,0.002387918,0.0005140494,0.0001612945,0.0004603368],"domain_scores_gemma":[0.9967073,0.0008013743,0.001580071,0.0004407258,0.000426519,0.00004402693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1472744,0.01576773,0.8171712,0.0003689171,0.0109404,0.00003556737,0.004924919,0.00004661531,0.001930416,0.0002540388,0.0004659533,0.0008198566],"study_design_scores_gemma":[0.7821635,0.01898466,0.1774651,0.0002883713,0.002069508,0.000009128639,0.009915711,0.0001928577,0.008320372,0.0001246798,0.00004104625,0.0004250907],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927943,0.0003497901,0.00001297976,0.0001391152,0.0001448053,0.00574028,0.0007930175,0.00001452279,0.00001123833],"genre_scores_gemma":[0.9984019,0.0000160306,0.00003841893,0.0000558305,0.000001773618,0.000638727,0.0008240071,0.00001729682,0.000006011007],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6397061,"threshold_uncertainty_score":0.9935128,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0430836626147483,"score_gpt":0.3498776452815406,"score_spread":0.3067939826667924,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}